278 related articles for article (PubMed ID: 30580645)
21. Temozolomide for the treatment of recurrent supratentorial glioma: results of a compassionate use program in Belgium.
Everaert E; Neyns B; Joosens E; Strauven T; Branle F; Menten J
J Neurooncol; 2004 Oct; 70(1):37-48. PubMed ID: 15527106
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow response as a potential biomarker of outcomes in glioblastoma patients.
Vaios EJ; Nahed BV; Muzikansky A; Fathi AT; Dietrich J
J Neurosurg; 2017 Jul; 127(1):132-138. PubMed ID: 27739940
[TBL] [Abstract][Full Text] [Related]
23. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.
Saito T; Sugiyama K; Takeshima Y; Amatya VJ; Yamasaki F; Takayasu T; Nosaka R; Muragaki Y; Kawamata T; Kurisu K
J Neurosurg; 2018 Mar; 128(3):679-684. PubMed ID: 28430038
[TBL] [Abstract][Full Text] [Related]
24. A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma.
Huang J; Chaudhary R; Cohen AL; Fink K; Goldlust S; Boockvar J; Chinnaiyan P; Wan L; Marcus S; Campian JL
J Neurooncol; 2019 May; 142(3):537-544. PubMed ID: 30771200
[TBL] [Abstract][Full Text] [Related]
25. Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.
Taal W; Segers-van Rijn JM; Kros JM; van Heuvel I; van der Rijt CC; Bromberg JE; Sillevis Smitt PA; van den Bent MJ
J Neurooncol; 2012 May; 108(1):195-200. PubMed ID: 22396071
[TBL] [Abstract][Full Text] [Related]
26. A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma.
Dinnes J; Cave C; Huang S; Milne R
Br J Cancer; 2002 Feb; 86(4):501-5. PubMed ID: 11870527
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
28. Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas.
Newlands ES; Foster T; Zaknoen S
Br J Cancer; 2003 Jul; 89(2):248-51. PubMed ID: 12865911
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of hemoglobin level and other factors in patients with high-grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide: a 10-year experience at a single institution.
Céfaro GA; Genovesi D; Vinciguerra A; Trignani M; Taraborrelli M; Augurio A; Buonaguidi R; Galzio RJ; Di Nicola M
Strahlenther Onkol; 2011 Dec; 187(12):778-83. PubMed ID: 22127356
[TBL] [Abstract][Full Text] [Related]
30. Glioblastoma treatment in the elderly in the temozolomide therapy era.
Coate L; McNamara MG; Lwin Z; Macfadden D; Al-Zahrani A; Massey C; Menard C; Millar BA; Sahgal A; Laperriere N; Mason WP
Can J Neurol Sci; 2014 May; 41(3):357-62. PubMed ID: 24718821
[TBL] [Abstract][Full Text] [Related]
31. Temozolomide chemotherapy in patients with recurrent malignant gliomas.
Yang SH; Kim MK; Lee TK; Lee KS; Jeun SS; Park CK; Kang JK; Kim MC; Hong YK
J Korean Med Sci; 2006 Aug; 21(4):739-44. PubMed ID: 16891823
[TBL] [Abstract][Full Text] [Related]
32. Narrative review of palliative hypofractionated radiotherapy for high grade glioma.
Saeed H; Tseng YD; Lo SS
Ann Palliat Med; 2021 Jan; 10(1):846-862. PubMed ID: 33040565
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up results of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastoma multiforme patients. The importance of MRI information in survival: Single-center experience.
Lukács G; Tóth Z; Sipos D; Csima M; Hadjiev J; Bajzik G; Cselik Z; Semjén D; Repa I; Kovács Á
Ideggyogy Sz; 2018 Mar; 71(3-04):95-103. PubMed ID: 29889468
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.
Paravati AJ; Heron DE; Landsittel D; Flickinger JC; Mintz A; Chen YF; Huq MS
J Neurooncol; 2011 Aug; 104(1):339-49. PubMed ID: 21181233
[TBL] [Abstract][Full Text] [Related]
35. MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma.
Sadones J; Michotte A; Veld P; Chaskis C; Sciot R; Menten J; Joossens EJ; Strauven T; D'Hondt LA; Sartenaer D; Califice SF; Bierau K; Svensson C; De Grève J; Neyns B
Eur J Cancer; 2009 Jan; 45(1):146-53. PubMed ID: 18945611
[TBL] [Abstract][Full Text] [Related]
36. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
[TBL] [Abstract][Full Text] [Related]
37. Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.
da Fonseca CO; Linden R; Futuro D; Gattass CR; Quirico-Santos T
Arch Immunol Ther Exp (Warsz); 2008; 56(4):267-76. PubMed ID: 18726148
[TBL] [Abstract][Full Text] [Related]
38. Fasting enhances the response of glioma to chemo- and radiotherapy.
Safdie F; Brandhorst S; Wei M; Wang W; Lee C; Hwang S; Conti PS; Chen TC; Longo VD
PLoS One; 2012; 7(9):e44603. PubMed ID: 22984531
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics of ATP binding cassette transporter MDR1(1236C>T) gene polymorphism with glioma patients receiving Temozolomide-based chemoradiation therapy in Indian population.
Munisamy M; Munisamy S; Kumar JP; Jose A; Thomas L; Baburaj G; Subbiah V
Pharmacogenomics J; 2021 Apr; 21(2):262-272. PubMed ID: 33589792
[TBL] [Abstract][Full Text] [Related]
40. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.
Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]